Author

Florence M.G. Cavalli

InsermORCID 0000-0002-4409-9642Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:deep learning· 2 Organism:human· 2 Approach:statistical model· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:clustering· 1 Research Focus:drug response / drug discovery· 1 Assay:scATAC-seq· 1

Frequent Co-Authors

Adam C Resnick· 1 shared Alexandra BomaneiD· 1 shared Alvaro A. MartineziD· 1 shared Ana Guerreiro StückliniD· 1 shared Andrea Joseph De MicheliiD· 1 shared Andreas Postlmayr· 1 shared Baptiste MouyssetiD· 1 shared Carlos Alberto Oliveira de BiagiiD· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Adam C Resnick

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Single-cell multi-omic analyses resolve the cellular diversity of ALK/ROS1/MET/NTRK-fused gliomas in infants and older children

Andrea Joseph De Micheli, Carlos Alberto Oliveira de Biagi, Costanza Lo Cascio, Charbel Machaalani, Andreas Postlmayr, Shashank Katiyar, Roeltje R. Maas, Venkatesh Kancherla, Regina Reimann, Michal Zápotocký, Liana Figueiredo Nobre, Sebastian K. Eder, Jacob S Rozowsky, Théo Ribierre, Fides Lea Zenk, , Ana Guerreiro Stücklin

The paper uses single-cell and spatial multi-omic analyses to characterize cellular diversity in RTK-fused gliomas across pediatric age groups, identifying distinct cancer cell states and myeloid subgroups.

bioRxiv · Jul 16, 2026 · PreprintCancer Biology

Reverse molecular pharmacology identifies the non-canonical axis of IRAK as a chemoresistance factor in neuroblastoma

Marion Le Grand, Chen Buxbaum, Mathilde Kerhervé, Flavie Gaucher, Alvaro A. Martinez, Mohammed Taha, Kévin Müller, Baptiste Mouysset, Alexandra Bomane, Sébastien Letard, Tim W. Failes, Greg M. Arndt, Seimia Chebbi, Emmanuel Labaronne, Florence M.G. Cavalli, , Eddy Pasquier

This study identifies IRAK1 as a chemoresistance factor in neuroblastoma and shows synergy between IRAK1 inhibition and various drugs in preclinical models.

bioRxiv · Jan 9, 2026 · PreprintCancer Biology